Overview Fundamentals API Earnings EOD API Sample Code Pricing

NextCure  Inc (NXTC NASDAQ) stock market data APIs

$1.7 0.02(1.2%) as of July 18, 2024
Price chart is built with Anychart

NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company is developing NC410, an immunomedicine designed to block immune suppression mediated by LAIR-1; NC762, a monoclonal antibody that binds specifically to B7-H4, a protein expressed on multiple tumor types; and NC525, a monoclonal antibody that binds to LAIR-1 to functionally kill AML blast cells and leukemic stem cells while preserving normal blood cells, including hematopoietic stem cells. Its discovery and research programs include an antibody in preclinical evaluation of other potential novel immunomodulatory molecules. It has a license agreement with Yale University. The company was incorporated in 2015 and is headquartered in Beltsville, Maryland.

NextCure  Inc Financial Data Overview

49 233 K
27 973 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'NXTC',
Type: 'Common Stock',
Name: 'NextCure  Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00BTH5153',
CIK: '1661059',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2019-05-09',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,

NextCure  Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -62 814 000
  • Earnings Per Share -2.28
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get NextCure  Inc Earnings via APIs

  • Latest Release 2024-05-02
  • EPS/Forecast -0.46

Get NextCure  Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?